nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefacetrile—SLC22A8—Methotrexate—testicular cancer	0.589	0.589	CbGbCtD
Cefacetrile—SLC22A6—Methotrexate—testicular cancer	0.41	0.41	CbGbCtD
